Evaluating the surface expression of Syn-1 on P3F1-positive RMS cancer cells
Research Grant
Administered By
Pharmacology & Cancer Biology
Awarded By
Retroviral Therapeutics (RTVX)
Start Date
February 1, 2025
End Date
January 31, 2026
Administered By
Pharmacology & Cancer Biology
Awarded By
Retroviral Therapeutics (RTVX)
Start Date
February 1, 2025
End Date
January 31, 2026